期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌与抑癌基因甲基化及MicroRNA的研究进展 被引量：3

下载PDF
导出
摘要 抑癌基因DNA的异常甲基化在肿瘤的发生与演进过程中起着重要作用,最近研究发现MicroRNA表达与多种癌症相关,并且受表观遗传学改变的控制。该文对乳腺癌抑癌基因甲基化及MicroRNA和乳腺癌的发生机制及治疗的研究进展作一综述。
作者 林帅 吴诚义
机构地区 重庆医科大学附属第一医院内分泌外科
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2010年第1期89-93,共5页 Chinese Journal of Clinical and Experimental Pathology
关键词 乳腺肿瘤 抑癌基因 DNA甲基化 MICRORNA
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献34

  • 1Robertson K D.DNA methylation and human disease[J].Nat Rev Genet,2005,6(8):597-610.
  • 2Wilson A S,Power B E,Molloy P L.DNA hypomethylation and human diseases[J].Bio Chim Biophys Acta,2007,1775(1):138-62.
  • 3Nakagawa T,Kanai Y,Ushiiima S,et al.DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas[J].J Urol,2005,173(1):243-6.
  • 4Ehrlich M.DNA methylation in cancer:too much,but also too little[J].Oncogene,2002,21(35):5400-10.
  • 5Issa J P.CpG island methylator phenotype in cancer[J].Nat Rev Cancer,2004,4(12):988-93.
  • 6Herman J G,Baylin S B.Gene silencing in cancer in association with promoter hypermethylation[J].N Engl J Med,2003,349:2042-54.
  • 7Esteller M,Silva J M,Dominguez G,et al.Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors[J].J Natl Cancer Inst,2000,92(7):564-9.
  • 8Esteller M.Cancer epigenomics:DNA methylomes and histone-modification maps[J].Nat Rev Genet,2007,8(4):286-98.
  • 9Wong D J,Paulson T G,Prevo L J,et al.p16(INK4a) lesions are common,early abnormalities that undergo clonal expansion in Barrett′s metaplastic epithelium[J].Cancer Res,2001,61(22):8284-9.
  • 10Esteller M,Corn P G,Baylin S B,et al.A gene hypermethylation profile of human cancer[J].Cancer Res,2001,61(8):3225-9.

二级参考文献30

  • 1Gomez D E,Alonso D F,Yoshiji H,et al.Tissue inhibitors of metalloproteinases:structure,regulation and biological functions[J].Eur J Cell Biol,1997,74:111-122.
  • 2Wick M,Burger C,Brusselbach S,et al.A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression,mitogenic stimulation,differentiation,and senescence[J].J Biol Chem,1994,269:18953-18960.
  • 3Leco K J,Khokha R,Pavloff N,et al.Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues[J].J Biol Chem,1994,269:9352-9360.
  • 4Birkedal-Hansen H,Moore W G,Bodden M K,et al.Matrix metalloproteinases:a review[J].Crit Rev Oral Biol Med,1993,4:197-250.
  • 5Liotta L A,Steeg P S,Stetler-Stevenson W G.Cancer metastasis and angiogenesis:an imbalance of positive and negative regulation[J].Cell,1991,64:327-336.
  • 6McDonald L E,Kay G F.Methylation analysis using bisulfite genomic sequencing:application to small numbers of intact cells[J].Biotechniques,1997,22:272-274.
  • 7Herman J G,Graff J R,Myohanen S,et al.Methylation-specific PCR:a novel PCR assay for methylation status of CpG islands[J].Proc Natl Acad Sci U S A,1996,93:9821-9826.
  • 8Singal R,Ginder G D.DNA methylation[J].Blood,1999,93:4059-4070.
  • 9Kang S H,Choi H H,Kim S G,et al.Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by dna hypermethylation of the 5′-CpG island in human gastric cancer cell lines[J].Int J Cancer,2000,86:632-635.
  • 10Bachman K E,Herman J G,Corn P G,et al.Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney,brain,and other human cancers[J].Cancer Res,1999,59:798-802.

共引文献10

同被引文献39

  • 1孙树汉.肿瘤的表观遗传学研究[J].中国肿瘤生物治疗志,2008(1)8-13.
  • 2Illingworth R S, Bird A P.CpG islands-'a rough guide'[J]. FEBS Lett, 2009, 583(11):1713-1720.
  • 3Jones P A, Baylin S B. The epigenomics of cancer[J]. Cell, 2007, 128(4): 683- 692.
  • 4Forsterov K, Votavovi H, Schwarz J, et al. Advanced rai stage in patients with chronic lymphocytic leukaemia correlates with simul- taneous hypermethylafion of plural tumour suppressor genes[J]. Folia Biol (Praha), 2010, 56(4):158-164.
  • 5Das P M, Singal R. DNA methylation and cancer[J]. J Clin Oncol, 2004.22 (22):4632-4642.
  • 6Shukeir N, Pakneshan P, Chen G P, et al. Alteration of the methy- lation status of tumor-promoting genes decreases prostate cancer cell invasivcness and tumorigenesis in vitro and in vivo[J]. Cancer Res, 2006, 66(18):9202-9210.
  • 7Verdonc L, Agricola E, Caserta M, et al. Histone acetylation in gent regulation[J]. Brief Funct Genomic Proteomic, 2006, 5(3):209-221.
  • 8Dhalluin C, Carlson l E, Zeng L, et al. Structure and ligand of a histone acetyltransfemse bromodomain[J]. Nature, 1999, 399(6735): 491-496.
  • 9Suzuki J, Chen Y Y, Scott G K, et al. Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression[J]. Clin Cancer Res, 2009, 15(9):3163-3171.
  • 10Van Den Broeck A, Brambilla E, Moro-Sibilot D, et al. Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer[J].Clin Cancer Res, 2008, 14(22):7237-7245.

引证文献3

二级引证文献7

临床与实验病理学杂志
2010年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部